Family Planning Through Dairy Cooperatives
Condition: The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through; Land O' Lakes-supported Dairy Cooperatives
Study type: Observational

Summary: 
      This observational study will assess a model for providing family planning through quarterly
      events organized by dairy cooperatives supported by Land O'Lakes in Kenya.
    

Detailed description: 
      Access to family planning and other reproductive health services remains difficult in much of
      rural Kenya. One option for improving rural access to family planning is to use existing
      community events outside of the health sector as platforms for delivering information and
      services. This study will assess a model for providing family planning through quarterly
      events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these
      events, known as Field Days, a healthcare provider will have a tent in which Field Day
      attendees can receive basic family health services free of charge. The services offered will
      be: family planning counseling and methods, immunizations, antenatal care, screening and
      treatment for sexually transmitted infections, and HIV counseling and testing. Since the
      services are no different than those that could be obtained at Ministry of Health or some
      private facilities, the service provision is not considered to be part of the research.

      Women receiving any service from the health care provider will be recruited for an interview
      that will measure their demand for family planning and attitudes about receiving services
      during the field day. In addition, the study will track the number of different types of
      services provided, the total number of Field Day attendees, and the cost of the service
      model. The study will be carried out at five Field Days in Rift Valley and Central provinces.

      Participants will not be tested for STI/HIV as part of this research; however, at their
      request, they may have received a test from the provider prior to the research interview. At
      the time of consent, they will have already received the test, so the consent form will not
      include anything specific to testing. In Kenya, all STI/HIV test results are reported to the
      national public health authorities. These reports are not used for contacting patients but
      for planning purposes.
    

Sampling method: Non-Probability Sample
Study population: 
        Females aged 18-49
      
Keywords: AE adverse event; AIDS acquired immunodeficiency syndrome; ALT (SGPT) alanine aminotransferase; ART antiretroviral therapy; AST (SGOT) aspartate aminotransferase; DCF data collection forms; DMC Data Monitoring Committee; FDA (U.S.) Food and Drug Administration; GCP Good Clinical Practice guidelines; HB sAg Hepatitis B surface antigen; ICH International Conference of Harmonisation; IND Investigational New Drug Application; IRB Institutional Review Board; IU International units; mg milligram(s); mm3 cubic millimeter(s); PCR polymerase chain reaction; SAE serious adverse event; µg microgram; ULN upper limit of the normal range; WB Western Blot